发明名称 |
Pharmaceutical combination for the treatment of cancer |
摘要 |
In accordance with the present invention there is provided a pharmaceutical combination useful for the treatment of cancer comprising at least one active compound of formula (I): and at least one further therapeutic agent chosen from a nucleoside analogue and/or a chemotherapeutic agents; and, a method of treating a patient having cancer comprising at least one active compound of formula (I), as defined above, and at least one further therapeutic agent chosen from a nucleoside analogue and/or a chemotherapeutic agents.
|
申请公布号 |
US2003083316(A1) |
申请公布日期 |
2003.05.01 |
申请号 |
US20020104067 |
申请日期 |
2002.03.25 |
申请人 |
SHIRE BIOCHEM INC. |
发明人 |
GILES FRANCIS;KANTARJIAN HAGPOP;JOLIVET JACQUES |
分类号 |
C07D405/04;A61K31/513;A61K31/704;A61K31/7064;A61K31/7068;A61K45/06;A61P1/18;A61P35/00;A61P35/02;(IPC1-7):A61K31/675 |
主分类号 |
C07D405/04 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|